ACUTA CAPITAL PARTNERS, LLC Hedge Fund

CIK: 0001582844 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 14, 2025

Total Value ($000): $99,404 (100.0% shares, 0.0% debt)

Holdings (39)

OCUL OCULAR THERAPEUTIX INC 9.5%

Value ($000) $9,489 Shares 1,111,071 Est. Cost $5.09 Unrealized +91.5%

INSM INSMED INC 7.3%

Value ($000) $7,235 Shares 104,800 Est. Cost $43.55 Unrealized +65.4%

— TOURMALINE BIO INC 7.2%

Value ($000) $7,135 Shares 351,842 Est. Cost $25.17 Unrealized —

CRNX CRINETICS PHARMACEUTICALS IN 6.3%

Value ($000) $6,284 Shares 122,900 Est. Cost $31.34 Unrealized +78.5%

ELVN ENLIVEN THERAPEUTICS INC 6.1%

Value ($000) $6,016 Shares 267,368 Est. Cost $16.47 Unrealized +57.4%

WHWK AADI BIOSCIENCES INC 5.9%

Value ($000) $5,835 Shares 1,849,402 Est. Cost $27.48 Unrealized -91.8%

PRAX PRAXIS PRECISION MEDICINES I 5.2%

Value ($000) $5,195 Shares 67,500 Est. Cost $26.38 Unrealized +174.3%

RVMD REVOLUTION MEDICINES INC 4.9%

Value ($000) $4,886 Shares 111,700 Est. Cost $24.90 Unrealized +102.6%

ARGX ARGENX SE 4.3%

Value ($000) $4,250 Shares 6,910 Est. Cost $487.88 Unrealized —

PCVX VAXCYTE INC 3.7%

Value ($000) $3,684 Shares 45,000 Est. Cost $43.67 Unrealized +127.4%

TRVI TREVI THERAPEUTICS INC 3.2%

Value ($000) $3,180 Shares 771,958 Est. Cost $3.05 Unrealized +5.0%

ASND ASCENDIS PHA-ADR 3.2%

Value ($000) $3,163 Shares 22,976 Est. Cost $148.31 Unrealized —

MREO MEREO BIOPHARMA GROUP PL-ADR 2.7%

Value ($000) $2,728 Shares 779,308 Est. Cost $3.74 Unrealized —

DRUG BRIGHT MINDS BIOSCIENCES INC 2.5%

Value ($000) $2,490 Shares 69,124 Est. Cost $35.19 Unrealized 0.0%

TERN TERNS PHARMACEUTICALS INC 2.5%

Value ($000) $2,479 Shares 447,500 Est. Cost $6.33 Unrealized +7.1%

EWTX EDGEWISE THERAPEUTICS INC 2.4%

Value ($000) $2,340 Shares 87,658 Est. Cost $23.25 Unrealized +36.9%

BBOT HELIX ACQUISITION CORP II 1.9%

Value ($000) $1,900 Shares 180,945 Est. Cost $10.29 Unrealized +2.1%

— UNICYCIVE THERAPEUTICS INC 1.8%

Value ($000) $1,829 Shares 2,303,000 Est. Cost $0.46 Unrealized —

RCKT ROCKET PHARMACEUTICALS INC 1.7%

Value ($000) $1,691 Shares 134,500 Est. Cost $18.58 Unrealized -19.0%

LQDA LIQUIDIA CORPORATION 1.6%

Value ($000) $1,619 Shares 137,709 Est. Cost $10.93 Unrealized +0.0%

— MERSANA THERAPEUTICS INC 1.6%

Value ($000) $1,602 Shares 1,120,500 Est. Cost $2.28 Unrealized —

TSHA TAYSHA GENE THERAPIES INC 1.5%

Value ($000) $1,530 Shares 884,244 Est. Cost $1.87 Unrealized +11.1%

TECX TECTONIC THERAPEUTIC INC 1.5%

Value ($000) $1,524 Shares 33,008 Est. Cost $32.32 Unrealized +30.8%

— CIDARA THERAPEUTICS INC 1.5%

Value ($000) $1,464 Shares 54,473 Est. Cost $26.88 Unrealized —

NAMS NEWAMSTERDAM PHARMA CO NV 1.3%

Value ($000) $1,285 Shares 50,000 Est. Cost $21.24 Unrealized 0.0%

ZYME ZYMEWORKS INC 1.0%

Value ($000) $984 Shares 67,240 Est. Cost $13.98 Unrealized 0.0%

ELDN ELEDON PHARMACEUTICALS INC 1.0%

Value ($000) $971 Shares 235,750 Est. Cost $3.94 Unrealized 0.0%

— VERVE THERAPEUTICS INC 0.9%

Value ($000) $904 Shares 160,200 Est. Cost $4.91 Unrealized —

RARE ULTRAGENYX PHARMACEUTICAL INC 0.9%

Value ($000) $883 Shares 21,000 Est. Cost $50.94 Unrealized -2.6%

GILD GILEAD SCIENCES INC 0.9%

Value ($000) $845 Shares 9,150 Est. Cost $73.07 Unrealized +19.1%

ACLX ARCELLX INC 0.8%

Value ($000) $824 Shares 10,743 Est. Cost $53.14 Unrealized +62.6%

SGMO SANGAMO THERAPEUTICS INC 0.8%

Value ($000) $755 Shares 740,000 Est. Cost $1.83 Unrealized 0.0%

— THIRD HARMONIC BIO INC 0.5%

Value ($000) $512 Shares 49,800 Est. Cost $11.31 Unrealized —

ARTV ARTIVA BIOTHERAPEUTICS INC 0.4%

Value ($000) $444 Shares 44,000 Est. Cost $11.59 Unrealized +3.6%

FBRX FORTE BIOSCIENCES INC 0.4%

Value ($000) $412 Shares 18,139 Est. Cost $11.89 Unrealized 0.0%

CRVS CORVUS PHARMACEUTICALS INC 0.4%

Value ($000) $398 Shares 74,307 Est. Cost $7.47 Unrealized 0.0%

CELC CELCUITY INC 0.3%

Value ($000) $327 Shares 25,000 Est. Cost $16.72 Unrealized -15.6%

RAPP RAPPORT THERAPEUTICS INC 0.3%

Value ($000) $291 Shares 16,400 Est. Cost $23.15 Unrealized -4.3%

— NUVATION BIO INC -CW27 0.0%

Value ($000) $21 Shares 90,832 Est. Cost $0.28 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
OCUL	OCULAR THERAPEUTIX INC	1,111,071	$9,489	9.5%	$5.09	+91.5%	COM	67576A100
INSM	INSMED INC	104,800	$7,235	7.3%	$43.55	+65.4%	COM PAR $.01	457669307
—	TOURMALINE BIO INC	351,842	$7,135	7.2%	$25.17	—	COM	89157D105
CRNX	CRINETICS PHARMACEUTICALS IN	122,900	$6,284	6.3%	$31.34	+78.5%	COM	22663K107
ELVN	ENLIVEN THERAPEUTICS INC	267,368	$6,016	6.1%	$16.47	+57.4%	COM	29337E102
WHWK	AADI BIOSCIENCES INC	1,849,402	$5,835	5.9%	$27.48	-91.8%	COM	00032Q104
PRAX	PRAXIS PRECISION MEDICINES I	67,500	$5,195	5.2%	$26.38	+174.3%	COM	74006W207
RVMD	REVOLUTION MEDICINES INC	111,700	$4,886	4.9%	$24.90	+102.6%	COM	76155X100
ARGX	ARGENX SE	6,910	$4,250	4.3%	$487.88	—	SPONSORED ADR	04016X101
PCVX	VAXCYTE INC	45,000	$3,684	3.7%	$43.67	+127.4%	COM	92243G108
TRVI	TREVI THERAPEUTICS INC	771,958	$3,180	3.2%	$3.05	+5.0%	COM	89532M101
ASND	ASCENDIS PHA-ADR	22,976	$3,163	3.2%	$148.31	—	SPONSORED ADR	04351P101
MREO	MEREO BIOPHARMA GROUP PL-ADR	779,308	$2,728	2.7%	$3.74	—	SPON ADS	589492107
DRUG	BRIGHT MINDS BIOSCIENCES INC	69,124	$2,490	2.5%	$35.19	0.0%	COM NEW	10919W405
TERN	TERNS PHARMACEUTICALS INC	447,500	$2,479	2.5%	$6.33	+7.1%	COM	880881107
EWTX	EDGEWISE THERAPEUTICS INC	87,658	$2,340	2.4%	$23.25	+36.9%	COM	28036F105
BBOT	HELIX ACQUISITION CORP II	180,945	$1,900	1.9%	$10.29	+2.1%	CL A ORD SHS	G4444H101
—	UNICYCIVE THERAPEUTICS INC	2,303,000	$1,829	1.8%	$0.46	—	COM	90466Y103
RCKT	ROCKET PHARMACEUTICALS INC	134,500	$1,691	1.7%	$18.58	-19.0%	COM	77313F106
LQDA	LIQUIDIA CORPORATION	137,709	$1,619	1.6%	$10.93	+0.0%	COM NEW	53635D202
—	MERSANA THERAPEUTICS INC	1,120,500	$1,602	1.6%	$2.28	—	COM	59045L106
TSHA	TAYSHA GENE THERAPIES INC	884,244	$1,530	1.5%	$1.87	+11.1%	COM SHS	877619106
TECX	TECTONIC THERAPEUTIC INC	33,008	$1,524	1.5%	$32.32	+30.8%	COM	878972108
—	CIDARA THERAPEUTICS INC	54,473	$1,464	1.5%	$26.88	—	COM NEW	171757206
NAMS	NEWAMSTERDAM PHARMA CO NV	50,000	$1,285	1.3%	$21.24	0.0%	ORDINARY SHARES	N62509109
ZYME	ZYMEWORKS INC	67,240	$984	1.0%	$13.98	0.0%	COM	98985Y108
ELDN	ELEDON PHARMACEUTICALS INC	235,750	$971	1.0%	$3.94	0.0%	NaN	28617K101
—	VERVE THERAPEUTICS INC	160,200	$904	0.9%	$4.91	—	COM	92539P101
RARE	ULTRAGENYX PHARMACEUTICAL INC	21,000	$883	0.9%	$50.94	-2.6%	COM	90400D108
GILD	GILEAD SCIENCES INC	9,150	$845	0.9%	$73.07	+19.1%	COM	375558103
ACLX	ARCELLX INC	10,743	$824	0.8%	$53.14	+62.6%	COMMON STOCK	03940C100
SGMO	SANGAMO THERAPEUTICS INC	740,000	$755	0.8%	$1.83	0.0%	COM	800677106
—	THIRD HARMONIC BIO INC	49,800	$512	0.5%	$11.31	—	COM	88427A107
ARTV	ARTIVA BIOTHERAPEUTICS INC	44,000	$444	0.4%	$11.59	+3.6%	COM	04317A107
FBRX	FORTE BIOSCIENCES INC	18,139	$412	0.4%	$11.89	0.0%	COM NEW	34962G208
CRVS	CORVUS PHARMACEUTICALS INC	74,307	$398	0.4%	$7.47	0.0%	COM	221015100
CELC	CELCUITY INC	25,000	$327	0.3%	$16.72	-15.6%	COM	15102K100
RAPP	RAPPORT THERAPEUTICS INC	16,400	$291	0.3%	$23.15	-4.3%	COM	75383L102
—	NUVATION BIO INC -CW27	90,832	$21	0.0%	$0.28	—	*W EXP 07/07/2027	67080N119